University of Malaya Medical Centre (UMMC) (Malay: Pusat Perubatan Universiti Malaya, abbr: PPUM), formerly known as University Hospital, is a government-funded medical institution located in Pantai Dalam, southwest corner of Kuala Lumpur, Malaysia. It was established by Statute in September 1962 and is part of University of Malaya. It serves as the teaching hospital for the Faculty of Medicine, University of Malaya and is the largest and oldest teaching hospital in Malaysia. The UMMC is also the second largest hospital in Malaysia.
Fibromatosis is a rare, benign, yet locally aggressive monoclonal fibroblastic proliferation. While current management paradigms increasingly favour non-operative strategies to avoid surgical morbidity and high recurrence rates, the role of surgery remains debated. This study aimed to evaluate the clinical presentation, management strategies, and oncological outcomes of fibromatosis at a single tertiary care centre. We conducted a retrospective, observational study of patients with histologically confirmed fibromatosis treated between January 2006 and September 2021. Data on patient demographics, tumour characteristics, treatment modalities, and disease status at last follow-up were analysed. Of 57 identified patients, 33 had complete records and were included. The cohort was predominantly female (81.82
Hand hygiene compliance among healthcare workers (HCWs) remains a critical challenge in infection prevention. Traditional audit methods have limitations, including observation bias and Hawthorne effect. This study used eye-tracking technology to as an objective behavioural tool to assess and compare of HCWs compliance with infection control measures in two teaching hospital in Malaysia. A prospective observational study was conducted across two hospitals (Hospital I and II). Participants performed standardized patient care scenarios incorporating the “5 Moments for Hand Hygiene” technique while wearing eye-tracking glasses to monitor the compliance of HCWs. Handrub duration, scrub-the-hub duration and gaze behavior including dwell time, fixation time and saccade on selected areas of interest were recorded. 75 HCWs (doctors and nurses) were recruited. Hospital I showed higher overall compliance (56.9
In recent years, artificial intelligence (AI) has made significant strides, gaining traction across various domains, including clinical medicine. The integration of AI as a decision-support tool introduces complexities, particularly in ensuring patient safety and upholding clinical accountability. This is especially pertinent in clinical neurophysiology (CNP), where AI shows promise in enhancing the interpretation of neurophysiologic data from modalities such as electroencephalography, electromyography, and others. Recognizing the potential and inherent challenges of AI integration, the International Federation of Clinical Neurophysiology (IFCN) has set forth guidelines to steer the responsible development, evaluation, and application of AI technologies in CNP.The IFCN’s core position on AI in CNP emphasizes improving healthcare outcomes, prioritizing patient-centered care, maintaining transparency in AI-generated interpretations, and supporting, rather than replacing, clinical expertise. As AI technology evolves, the IFCN stresses that models implemented in clinical practice, especially when lacking supervision by experts must meet stringent standards for accuracy, safety, and quality control, and that AI cannot substitute expert care without adequate oversight.The successful integration of AI in CNP hinges on dataset diversity, transparent and ethical training practices, and balancing model complexity with real-world validation. Continuous performance monitoring and clinician feedback are vital to maintaining AI system reliability over time.The IFCN envisions a future where AI ethically enhances CNP practice through multidisciplinary collaboration, focusing on patient safety, clinical integrity, and scientific rigor. Properly implemented, AI can revolutionize CNP by offering real-time decision support, personalized interventions, and remote monitoring, thus advancing the quality of care in CNP.
Ultrasound-guided hydrodissection (HD) is an emerging minimally invasive treatment for carpal tunnel syndrome (CTS); however, achieving circumferential perineural spread around the median nerve may require repeated needle repositioning, multiple skin entries, or combined in-plane and out-of-plane maneuvers, thereby increasing procedural complexity. This technical report describes a novel ultrasound-guided single-entry dual-target HD technique for CTS that sequentially addresses the undersurface of the transverse carpal ligament (TCL) and the perineural plane surrounding the median nerve through a standardized scanning approach initiated at the first carpometacarpal (1st CMC) joint and maintained during medial transducer translation across the carpal tunnel. The technique uses a structured in-plane distal-to-proximal trajectory to maintain continuous needle visualization while reaching both targets through a single skin entry. Importantly, the approach targets the deep surface of the TCL but does not constitute TCL release. For cadaveric validation, the same procedural approach was performed in one fresh-frozen cadaver using both wrists. Under ultrasound guidance, 10 mL of methylene blue was injected per wrist using a 23-gauge, 6-cm needle, followed by dissection. Cadaveric dissection demonstrated dye surrounding the median nerve on both its superficial and deep aspects, supporting circumferential perineural halo formation, with proximal longitudinal spread from the entry site. These findings support the anatomical plausibility of the intended HD plane. This structured single-entry dual-target approach may offer a practical technical framework for CTS hydrodissection; however, further prospective and comparative studies are required to determine its clinical efficacy, safety, and relative advantages over existing ultrasound-guided CTS techniques.
Objectives Organ damage in SLE is assessed using the SLICC/ACR Damage Index (SDI), which quantifies damage in 12 organ systems but generally reports a total score. We examined whether the risk factors for overall organ damage accrual captured those associated with domain-specific damage accrual in patients with SLE. Methods Data from a 13-country longitudinal SLE cohort were collected between 2013 and 2020 using standard templates. SDI was used to assess overall and domain-specific organ damage. A series of multi-failure, multivariate models were performed to examine the risk factors associated with overall and domain-specific damage accrual. Results A total of 3449 patients with a median of 2.8 [interquartile range (IQR): 1.1, 5.6] years of follow-up were studied. Twenty-one percent (n = 717) patients accrued damage in at least one domain during the study period (musculoskeletal, 6%; renal and ocular, 5% each, neuropsychiatric, 2.5%; <2%, other domains). Risk factors for damage accrual differed among domains. Older age, cumulative glucocorticoid dose, existing skin damage, and diabetes were strong predictors in multiple but discrete domains. Asian ethnicity conferred greater risk of ocular, musculoskeletal, and diabetic damage accrual but was protective against peripheral vascular damage accrual. Smoking was a significant risk factor for peripheral vascular and skin damage accrual, while male sex was associated with the malignancy domain. Conclusion Risk factors for individual organ system damage accrual were highly varied in patients with SLE. Not all factors associated with domain-specific damage accrual were captured by the risk factors analysed for overall organ damage accrual. Trial registration ClinicalTrials.gov, http://clinicaltrials.gov, NCT03138941.